Abstract Parietal foramina [PFM], inherited usually in an autosomal dominant mode, is an extremely rare developmental defect characterized by a symmetrical, oval hole in the parietal bone. It can be present as either an isolated or a syndromic feature. PFM types 1 and 2 (PFM1 and PFM2) have been found to be caused by mutations in the MSX2 and ALX4 genes, located to chromosomes 5 and 11, respectively. After exclusion of both the above loci in a large Chinese pedigree with autosomal dominant PFM, a genome-wide search revealed a linkage of the PFM to markers at the 4q21-q23 region. The maximum LOD score from two-point linkage analysis is 3.87 for marker D4S2961. Analysis of co-segregated haplotype localized the region to a 20-cM interval that flanks D4S392 and D4S2945. Therefore, we concluded that the PFM in the family is a new PFM locus. Although three genes, BMPR1B, PP1 and IBSP, are located to 4q21-q25 and their functions are related to bone morphogenesis, no mutations were identified by sequencing analysis of their exons.
Introduction
Parietal foramina (PFM) [MIM 168500 ] is an extremely rare congenital developmental anomaly of the parietal bone. The hereditary mode is usually autosomal dominant. PFM is characterized by symmetrical, oval defects in the parietal bone, normally obliterated during the fifth fetal month. They are situated on each side of the sagittal suture and separated from each other by a narrow bridge of bone. The size of the opening decreases with age and considerable intrafamilial variability is observed. PFM is benign and asymptomatic in most circumstances. However, seizures, scalp defects, and structural and vascular malformations of the brain can also occur simultaneously (Wilkie et al. 2000) . Available information showed that it occurs in Asians, Africans, Europeans and Native Americans (Little et al. 1990 ). Hereditary cranium bifidum is the same entity as symmetric PFM (Little et al. 1990; Zabek 1987) . Pang and Lin (1982) observed that the bilateral defects in one child evolved from a single midline opening via median ossification. PFM can be present as an isolated defect, but it can also be one of the characteristics of different syndromes (Golabi et al. 1984; Young and Swift 1985; Shaffer et al. 1993; Potocki and Shaffer 1996; Bartsch et al. 1996) . Bartsch et al. (1996) identified a deletion in the short arm of chromosome 11p13-p11 in a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation. Wu et al. (2000) found that ALX4 located at 11p11 was a candidate gene for the PFM in the 11p11.2 deletion syndrome, and mutations in ALX4 were identified for non-syndromic PFM, PFM type 1 (PFM1) (Wuyts et al. 2000a (Wuyts et al. ,2000b Mavrogiannis et al.2001) , while haploinsufficiency due to heterozygous mutations in the MSX2 homeobox gene located at 5q34-q35 could also cause PFM, PFM type 2 (PFM2) (Wilkie et al. 2000; Wuyts et al. 2000a Wuyts et al. ,2000b Cohen 2000) .
Here we report a new locus for non-syndromic PFM in a large Chinese pedigree.
Subjects and methods

Pedigree assessment
A large Chinese pedigree was identified through a proband who had typical features of PFM. All of the family members participated in the study and gave their informed consent. A total of 15 individuals (six males and nine females) in this four-generation family were affected with the defect. Nine of the affected and one normal individual were examined by cranial radiography. All the family members were carefully checked for multiple exostoses, craniofacial dysostosis, mental retardation, and other abnormal signs, but no syndromic forms were found. Hence, PFM was the only symptom found in the affected individuals of this family. All affected members had symmetrical, oval holes in their parietal bone.
Genotyping and linkage analysis Samples of peripheral blood were taken from all available family members, and DNA was isolated by means of the laboratory procedure described elsewhere (Yang et al. 2000) . First, a search was carried out on both chromosomes 11 and 5, because ALX4 was located on the former and MSX2 on the latter chromosome. However, no LOD score above 0 was obtained, so that a linkage was ruled out on these two chromosomes. A genome-wide screening was performed by a modified DNA-pooling method (Damji et al. 1998; Liu et al. 2001) . A total of 383 autosomal microsatellite marker loci were genotyped in this family, using the ABI PRISM Linkage Mapping Set (version 2, LMS2) (Perkin-Elmer, USA). The set consists of fluorescence-labeled PCR primer pairs for 400 highly polymorphic dinucleotide-repeat microsatellite markers chosen from the Ge´ne´thon human linkage map (Dib et al. 1996) . These markers have an average spacing of 10 cM. Markers on the X chromosome were not used, because a male-to-male transmission was present in this pedigree.
Three pools of DNA from affected (n=14), unaffected family members (n=4) and unrelated population controls (n=6) were established by combining equal amounts of DNA from each individual. The control individuals were spouses of members of this pedigree. Multiplex PCR was performed for each panel of markers in a 5-l l reaction volume containing 20 ng of pooling DNA, 3 mM MgCl 2 , 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 200 lM each dNTP, 0.05 lM of each primer pairs and 0.5 U of Hot StarTaq polymerase (Perkin-Elmer). Reactions were performed on a PerkinElmer 9700 thermal cycler, and a touch-down thermocycling profile was used for all markers, consisting of an initial denaturation at 94°C for 12 min, followed by 14 cycles each of denaturation at 94°C for 30 s, annealing at 63°C (decreased by 0.5°C each cycle) for 90 s, and synthesis at 72°C for 90 s. This was followed by 25 cycles, each of denaturation at 94°C for 30 s, annealing at 56°C for 90 s, synthesis at 72°C for 90 s, followed by an extension step at 72°C for 10 min, finally held at 4°C. PCR products for each panel of markers were size fractionated on a 5% denaturing polyacrylamide gel by electrophoresis on an ABI 377 PRISMR DNA sequencer (Perkin-Elmer). The products were sized by the Genescan (Perkin-Elmer) version 2.1 program and scored by the Genotyper (Perkin-Elmer) version 2.0 program. Allele graphs showing a unique or higher peak in an affected panel lane after comparing with that of the unaffected and population control lanes (unaffected lane in particular) were regarded as candidate markers for typing of all members in this family. On chromosome 4, D4S1572 and D4S2964 showed a significantly higher peak; therefore, a total of 16 markers were selected for further mapping around the markers. Microsatellite markers, including D4S2945, D4S2961, D4S1591, D4S421 D4S2986, D4S1560, and D4S1559, were synthesized according to the Ge´ne´thon human linkage map (Dib et al. 1996) . PCR and thermocycling conditions were exactly the same as those used for the LMS2 marker set.
Two-point linkage analysis was performed by the MLINK program of the LINKAGE 5.1 package (Lathrop et al. 1985) , based on a dominant inheritance model, with a disease penetrance of 0.95, and a disease gene frequency of 0.01. Allele frequencies and meiotic recombinations between the sexes were assumed to be equal. Multipoint linkage analysis was performed by the FAST-MAP program (Curtis and Gurling 1993) , with published intermarker genetic distances from Ge´ne´thon chromosome 4.
Results
Cranial X-ray photograph assessment Nine of 15 individuals affected with PFM in this pedigree were available for cranial radiography. The result showed that these nine affected individuals had symmetrical, oval opening holes in their parietal bones (Fig. 1) . Individual IV-1 carried a disease-associated haplotype, but her cranial X-ray showed no symmetrical holes on the parietal bone.
Linkage analysis
A total of 24 individuals available for genotyping were subjected to a chromosome-wide screening with all the markers from ABI LMS2 on chromosomes 5 and 11, since a linkage was previously identified on these chromosomal regions in non-sydromic PFM (Bartch et al., 1996; Wuyts et al.2000a Wuyts et al. ,2000b . Unfortunately, no linkage (LOD score ‡0) was found. Therefore, both PFM1 and PFM2 loci were excluded from the disorder in our pedigree.
A genome-wide scanning on DNA pooling samples showed that a total of 95 markers were unique or higher in graphic peak in the DNA pooling sample of affected individuals after comparing electropherograms among three groups of pooling samples. These markers were selected for fine mapping. Eventually, only D4S1572 and D4S2964 were confirmed to be linked to the PFM phenotype, the remaining positive peaks being false positive.
The maximum LOD score at h=0.00 for the two markers were 3.29 and 1.70, respectively. Further linkage analysis was refined with 14 additional short tandem repeat (STR) markers spanning a 20-cM region around D4S1572. The result of the two-point LOD scores is summarized in Table 1 . The highest two-point LOD score was 3.87 at D4S2961, whereas the multipoint LOD score reached the value of 6.17 between D4S2986 and D4S421 (Fig. 2) . Subsequently, all of the remaining markers in the LMS2 set were typed for further verification, but no linkage (LOD score ‡0) on other loci was found. The results suggested that the disease in our family is a new PFM locus located to 4q21-q23.
Haplotype analysis
Extended haplotypes of the pedigree were originally constructed by the computer program Cyrillic (Cherwell Scientific, version 2.1.3) and then verified by the GENEHUNTER2.1 program by dividing the pedigree into three parts (Kruglyak and Lander 1998) . The order of markers was based on the Ge´ne´thon genetic linkage 
The haplotypes were checked by view inspection, and a disease-linked haplotype was seen in all affected individuals (Fig. 3) . However, an unaffected individual, IV-1, carried the whole disease-associated haplotype, and both III-8 and III-10 carried partial diseased-associated haplotypes as well. From these findings it is most likely that the disease locus is within a 20-cM interval, flanked by D4S2964 and D4S2961, on chromosome 4q21-q23 (Fig. 3) .
Discussion
A total of 15 affected PFM individuals in this Chinese pedigree had typical clinical features, which are exactly the same as those reported previously (Fein and Brinker 1972; Okuda and Ikutomi 1965) . The parietal hole is the only sign and all affected individuals had no other symptoms in this family except for III-3 and III-11, who developed recurrent headaches. This is probably due to their relatively large parietal holes, as a similar symptom reported by Pang and Lin (1982) . Penetrance of PFM in this pedigree is incomplete. An unaffected individual, IV-1, carried the diseased haplotype, but she had no holes on her parietal bone. Both III-8 and III-10 carried partial disease-haplotypes. It remains to be investigated whether they are disease carriers with incomplete penetrance. Muscle segment homeobox homologue 2 is an important target for the RAS signaling pathways and it establishes a balance between survival and apoptosis of neural crest-derived cells required for proper craniofacial morphogenesis. Mutations in this gene (MSX2) resulted in decreased parietal ossification (Cohen 2000) . Heterozygous mutations or deletions in MSX2 have been found in patients with an isolated form of PFM from three unrelated British families (Wilkie et al. 2000) . Similar mutations in MSX2 in four of their five PFM families were found by a Belgian research group (Wuyts et al. 2000a (Wuyts et al. ,2000b . They suggested that haploinsufficiency of MSX2 resulted in the skull defect. Later, in their remaining family, a mutation in the aristaless-like homeobox 4 gene (ALX4) was identified (Wuyts et al. 2000a (Wuyts et al. ,2000b . ALX4 encodes a paired-related homeodomain transcription factor, which decreases the expression of endogenous N-CAM protein (Boras et al 2002) .
Another interesting finding was from a transgenic mouse model, where loss of MSX2 function could also induce holes in the mouse skull, but the location (frontal bone rather than the parietal bone) of the bony lesion is different from that of PFM in humans (Satokata et al. 2000) . Discovery of the two different genes causing PFM suggested that different proteins might belong to the same or disparate pathological pathway; i.e., heterogeneity exists in PFM.
We failed to prove any linkages between PFM and markers on chromosomes 5 and 11 in this Chinese pedigree, but obtained a linkage to 4q21-q23. These findings indicate the presence of a third locus (PFM3) for PFM. Genes related to bone morphogenesis in this region may become potential candidate for the putative PFM3 gene. The bone morphogenetic protein receptor type IB gene (BMPR1B) encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. BMPs are involved in endochondral bone formation and embryogenesis (Astrom et al 1999) . The secreted phosphoprotein 1 gene (SPP1) encodes osteopontin, which is a bone and blood vessel extracellular matrix protein involved in calcification and atherosclerosis (Reinholt et al 1990) . The integrin-binding sialoprotein gene (IBSP) encodes integrin-binding sialoprotein, which is a major structural protein of the bone matrix (Fisher et al 1990) . Although we performed sequence analysis of these genes, we did not find any point mutations or deletions in their coding regions. It remains to be seen whether mutations exist in other candidate genes within the 4q21-q23 region.
